Advances in anti-angiogenic agents for ovarian cancer treatment: The role of trebananib (AMG 386). (Q38382072)

From Wikidata
Jump to navigation Jump to search
scientific article published on 04 March 2015
edit
Language Label Description Also known as
English
Advances in anti-angiogenic agents for ovarian cancer treatment: The role of trebananib (AMG 386).
scientific article published on 04 March 2015

    Statements

    Advances in anti-angiogenic agents for ovarian cancer treatment: The role of trebananib (AMG 386). (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit